Dysregulation of Extracellular Matrix Genes Identifies Neuroblastoma Patients at High Risk of Recurrence and Poor Outcome
ECM gene signatures serve as robust prognostic markers across populations. This function-based approach offers a novel perspective to address genetic heterogeneity and provides a theoretical foundation for ECM-targeted combination therapies.
Authors
- Chaoban Wang
- S Y Ge
- Ju Gao (ORCID: https://orcid.org/0000-0001-5893-9406)
- Guoqian He
- Xiaoyu Jing
- Xia Guo
- Sijia He
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1097/mph.0000000000003160
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00